VERTEX PHARMACEUTICALS INC / MA
VRTX · XNASCIK 875320fmd_17RDSX9EHS4JAPTCN1CCDNFDKHIndustri Pengolahan · Sediaan FarmasiTemplat: Standar
Cakupan: 01 Jan 2008 hingga 30 Sep 2026, 72 periode
| Pos laporan | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total pendapatan | 1.702 | 2.489 | 3.048 | 4.163 | 6.206 | 7.574 | 8.931 | 9.869 | 11.020 | 12.001 |
| Beban pokok pendapatan | 210 | 275 | 410 | 548 | 736 | 904 | 1.080 | 1.262 | 1.531 | 1.651 |
| Pendapatan bunga bersih | – | – | – | (59) | (58) | (62) | (55) | (44) | – | – |
| Laba kotor | 1.492 | 2.214 | 2.638 | 3.615 | 5.469 | 6.670 | 7.850 | 8.607 | 9.490 | 10.350 |
| Penelitian dan pengembangan | 1.048 | 1.325 | 1.416 | 1.755 | 1.645 | 1.938 | 2.540 | 3.163 | 3.630 | 3.910 |
| Beban penjualan, umum dan administrasi | 433 | 496 | 558 | 658 | 770 | 840 | 945 | 1.137 | 1.464 | 1.753 |
| Laba operasi | 10 | 123 | 635 | 1.198 | 2.856 | 2.782 | 4.307 | 3.832 | (233) | 4.173 |
| Beban bunga | – | 69 | 72 | 59 | 58 | – | 55 | 44 | 31 | 13 |
| Pendapatan bunga dan investasi | – | 12 | 38 | 64 | 22 | 5 | 145 | 615 | 598 | 491 |
| Pendapatan (beban) nonoperasi lainnya | 4 | (81) | (1) | 192 | 297 | 5 | (165) | (23) | (86) | (8) |
| Laba sebelum pajak | (67) | (16) | 600 | 1.395 | 3.117 | 2.730 | 4.232 | 4.380 | 249 | 4.643 |
| Beban pajak penghasilan | 17 | (107) | (1.487) | 218 | 405 | 388 | 910 | 760 | 784 | 690 |
| Laba bersih dari operasi yang dilanjutkan | (84) | 92 | 2.087 | 1.177 | 2.712 | 2.342 | 3.322 | 3.620 | (536) | 3.953 |
| Laba bersih | (112) | 263 | 2.097 | 1.177 | 2.712 | 2.342 | 3.322 | 3.620 | (536) | 3.953 |
| Laba bersih yang diatribusikan kepada pemegang saham biasa | (112) | 263 | 2.096 | 1.177 | 2.712 | – | – | – | – | – |